FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1523760829> ?p ?o ?g. }

• W1523760829 endingPage "324" @default.
• W1523760829 startingPage "313" @default.
• W1523760829 abstract "The objective of this study was to evaluate the effect of pericyte coverage (PC) of differentiated tumor microvessels on the prognosis of patients with clear cell renal cell carcinoma (CCRCC).Samples from 2 cohorts of patients with CCRCC (101 Asian patients and 524 US patients) were prepared using 2 different histologic approaches: routine sectioning versus tissue microarray. Then, the samples were immunohistochemically doubled-stained for a pericyte marker (alpha smooth muscle actin [α-SMA]) and a differentiated vessel marker (cluster of differentiation 34 [CD34]), followed by multispectral image capturing and computerized image analyses to quantify the microvessel density (MVD) and the PC of differentiated vessels. The correlations of PC and the MVD:PC ratio with clinicopathologic characteristics were analyzed.There was an inverse correlation between differentiated MVD and PC. Higher PC correlated with more aggressive clinicopathologic characteristics of CCRCC in both cohorts, including more advanced T-classification, higher pathologic grades, and the occurrence of tumor necrosis. The MVD:PC ratio was an independent favorable prognostic factor for overall and recurrence-free survival in the Asian cohort and for recurrence-free survival in the US cohort. PC also was an independent prognostic factor, with higher PC predicting a poorer outcome. The combination of PC and MVD was better at distinguishing the outcome of patients with CCRCC. PC combined with differentiated MVD or with the MVD:PC ratio provided additional, independent prognostic information to the Leibovich risk model, and that information was used to generate improved risk models.The authors consistently observed that higher PC was correlated with more aggressive clinicopathologic characteristics. PC was an independent unfavorable prognostic factor. The authors concluded that pericytes should be considered for therapeutic targeting." @default.
• W1523760829 created "2016-06-24" @default.
• W1523760829 creator A5007893240 @default.
• W1523760829 creator A5011538072 @default.
• W1523760829 creator A5022629118 @default.
• W1523760829 creator A5024124543 @default.
• W1523760829 creator A5024708104 @default.
• W1523760829 creator A5025529463 @default.
• W1523760829 creator A5041631075 @default.
• W1523760829 creator A5055979464 @default.
• W1523760829 creator A5058127854 @default.
• W1523760829 creator A5064373607 @default.
• W1523760829 creator A5076351536 @default.
• W1523760829 creator A5078641175 @default.
• W1523760829 creator A5079551420 @default.
• W1523760829 creator A5085460226 @default.
• W1523760829 date "2012-07-18" @default.
• W1523760829 modified "2023-10-17" @default.
• W1523760829 title "Pericyte coverage of differentiated vessels inside tumor vasculature is an independent unfavorable prognostic factor for patients with clear cell renal cell carcinoma" @default.
• W1523760829 cites W114244261 @default.
• W1523760829 cites W1547714734 @default.
• W1523760829 cites W161033018 @default.
• W1523760829 cites W1982799945 @default.
• W1523760829 cites W2021565823 @default.
• W1523760829 cites W2022557634 @default.
• W1523760829 cites W2039545078 @default.
• W1523760829 cites W2043166238 @default.
• W1523760829 cites W2055437192 @default.
• W1523760829 cites W2066103087 @default.
• W1523760829 cites W2069480574 @default.
• W1523760829 cites W2072402342 @default.
• W1523760829 cites W2114559468 @default.
• W1523760829 cites W2115390024 @default.
• W1523760829 cites W2126810504 @default.
• W1523760829 cites W2137541604 @default.
• W1523760829 cites W2160328599 @default.
• W1523760829 cites W2316947292 @default.
• W1523760829 cites W4239180165 @default.
• W1523760829 cites W4308665337 @default.
• W1523760829 doi "https://doi.org/10.1002/cncr.27746" @default.
• W1523760829 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22811049" @default.
• W1523760829 hasPublicationYear "2012" @default.
• W1523760829 type Work @default.
• W1523760829 sameAs 1523760829 @default.
• W1523760829 citedByCount "42" @default.
• W1523760829 countsByYear W15237608292012 @default.
• W1523760829 countsByYear W15237608292013 @default.
• W1523760829 countsByYear W15237608292014 @default.
• W1523760829 countsByYear W15237608292015 @default.
• W1523760829 countsByYear W15237608292016 @default.
• W1523760829 countsByYear W15237608292017 @default.
• W1523760829 countsByYear W15237608292018 @default.
• W1523760829 countsByYear W15237608292019 @default.
• W1523760829 countsByYear W15237608292020 @default.
• W1523760829 countsByYear W15237608292021 @default.
• W1523760829 countsByYear W15237608292022 @default.
• W1523760829 crossrefType "journal-article" @default.
• W1523760829 hasAuthorship W1523760829A5007893240 @default.
• W1523760829 hasAuthorship W1523760829A5011538072 @default.
• W1523760829 hasAuthorship W1523760829A5022629118 @default.
• W1523760829 hasAuthorship W1523760829A5024124543 @default.
• W1523760829 hasAuthorship W1523760829A5024708104 @default.
• W1523760829 hasAuthorship W1523760829A5025529463 @default.
• W1523760829 hasAuthorship W1523760829A5041631075 @default.
• W1523760829 hasAuthorship W1523760829A5055979464 @default.
• W1523760829 hasAuthorship W1523760829A5058127854 @default.
• W1523760829 hasAuthorship W1523760829A5064373607 @default.
• W1523760829 hasAuthorship W1523760829A5076351536 @default.
• W1523760829 hasAuthorship W1523760829A5078641175 @default.
• W1523760829 hasAuthorship W1523760829A5079551420 @default.
• W1523760829 hasAuthorship W1523760829A5085460226 @default.
• W1523760829 hasBestOaLocation W15237608291 @default.
• W1523760829 hasConcept C10205521 @default.
• W1523760829 hasConcept C123012128 @default.
• W1523760829 hasConcept C126322002 @default.
• W1523760829 hasConcept C142724271 @default.
• W1523760829 hasConcept C193270364 @default.
• W1523760829 hasConcept C202751555 @default.
• W1523760829 hasConcept C204232928 @default.
• W1523760829 hasConcept C2776436680 @default.
• W1523760829 hasConcept C2777472916 @default.
• W1523760829 hasConcept C2778560582 @default.
• W1523760829 hasConcept C2780427682 @default.
• W1523760829 hasConcept C2781278892 @default.
• W1523760829 hasConcept C28328180 @default.
• W1523760829 hasConcept C54355233 @default.
• W1523760829 hasConcept C55493867 @default.
• W1523760829 hasConcept C71924100 @default.
• W1523760829 hasConcept C86803240 @default.
• W1523760829 hasConceptScore W1523760829C10205521 @default.
• W1523760829 hasConceptScore W1523760829C123012128 @default.
• W1523760829 hasConceptScore W1523760829C126322002 @default.
• W1523760829 hasConceptScore W1523760829C142724271 @default.
• W1523760829 hasConceptScore W1523760829C193270364 @default.
• W1523760829 hasConceptScore W1523760829C202751555 @default.
• W1523760829 hasConceptScore W1523760829C204232928 @default.
• W1523760829 hasConceptScore W1523760829C2776436680 @default.
• W1523760829 hasConceptScore W1523760829C2777472916 @default.

• next